CD40LG and myeloid sarcoma: Treatment naive MS patients did not differ in their Ig levels from controls, challenging the hypothesis of a previous study that MS in itself may cause hypoimmunoglobulinemia.13 We observed lower levels of IgM and IgG under therapy with FG, NZ, and BCDT compared with healthy controls.